Nuo Therapeutics, Inc. (AURX): Cost of Revenue
$1.10M
Year ended 2025-12-31
$1.87M
Trailing 12 months to 2026-06-30
n/m
3-year compound annual growth
-18.0%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.10M | +261.8% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $302.8K | +140.2% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $126.1K | +556.3% | 2025-04-01, From 2023-01-01 |
| 2022-12-31 | $19.2K | n/a | 2024-04-19, From 2022-01-01 |
| 2021-12-31 | $0 | n/a | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $0 | -100.0% | 2022-04-15, From 2020-01-01 |
| 2019-12-31 | $114.6K | -29.7% | 2022-04-15, From 2019-01-01 |
| 2018-12-31 | $163.0K | -85.1% | 2019-04-16, From 2018-01-01 |
| 2017-12-31 | $1.09M | n/a | 2019-04-16, From 2017-01-01 |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | $7.97M | +17.7% | 2016-10-24, From 2015-01-01 |
| 2014-12-31 | $6.77M | -19.9% | 2016-10-24, From 2014-01-01 |
| 2013-12-31 | $8.45M | +115.9% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $3.91M | +43.5% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $2.73M | +69.1% | 2013-03-18, From 2011-01-01 |
| 2010-12-31 | $1.61M | n/a | 2012-03-29, From 2010-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $1.10M | +261.8% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $2.15M | +17.0% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $2.31M | -14.9% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $1.59M | +1.3% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $880.9K | +13.8% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $2.17M | +19.9% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $6.67M | -6.0% |
| Femasys Inc (FEMY) | 2025-12-31 | $872.4K | +60.1% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $5.14M | +14.2% |
Compare AURX, ICCM, OSRH, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗